Benjamin Resio, MD
Assistant ProfessorAbout
Research
Publications
2025
Real-World Perioperative Outcomes of Neoadjuvant Chemoimmunotherapy in Non-Small Cell Lung Cancer
Caturegli G, Kaminski M, Canavan M, Ayoade O, Resio B, Boffa D. Real-World Perioperative Outcomes of Neoadjuvant Chemoimmunotherapy in Non-Small Cell Lung Cancer. JTCVS Open 2025 DOI: 10.1016/j.xjon.2025.09.016.Peer-Reviewed Original ResearchNon-small cell lung cancerPathological complete responseNational Cancer DatabaseNeoadjuvant chemoimmunotherapyCell lung cancerChemoimmunotherapy patientsNeoadjuvant chemoradiotherapyPerioperative outcomesStage I to III non-small cell lung cancerIII non-small cell lung cancerLung cancerTreated with neoadjuvant chemoimmunotherapyNon-small cell lung cancer recurrenceOutcome of immunotherapyPeri-operative outcomesMethods Adult patientsInduction chemoimmunotherapyComplete responseNeoadjuvant chemotherapyNodal downstagingPerioperative therapyCancer DatabasePneumonectomy rateChemoimmunotherapyAdult patientsMortality Risk and Cause of Death Associated with Removal of the Adult Thymus: Analysis of the US Thymoma Population
Resio B, Canavan M, Caturegli G, Detterbeck F, Boffa D. Mortality Risk and Cause of Death Associated with Removal of the Adult Thymus: Analysis of the US Thymoma Population. Journal Of Thoracic Oncology 2025 PMID: 40865907, DOI: 10.1016/j.jtho.2025.08.017.Peer-Reviewed Original ResearchSurveillance Epidemiology and End ResultsNational Cancer DatabaseDuctal carcinoma in situPropensity-matched patientsThyroid cancerAdult thymusU.S. populationImmunologic end pointsCarcinoma in situFive-year survivalCancer incidencePartial thymectomyThyroid lobectomyResected breastLonger-term outcomesPartial mastectomyThyroid neoplasmsTotal thymectomyCancer DatabaseCause of deathNo significant differenceSecondary cancersSmall thymomaThymectomyEnd ResultsProlonged Survival in Mesothelioma Patients without Surgical Resection: A National Cancer Database Analysis
Zhan P, Canavan M, Bader J, Boffa D, Resio B, Woodard G. Prolonged Survival in Mesothelioma Patients without Surgical Resection: A National Cancer Database Analysis. The Annals Of Thoracic Surgery 2025 PMID: 40588180, DOI: 10.1016/j.athoracsur.2025.06.015.Peer-Reviewed Original ResearchNational Cancer DatabaseLong-term survivalSurgical resectionOverall survivalPleural mesotheliomaClinical stage I diseaseCurative-intent surgical resectionNational Cancer Database dataNational Cancer Database AnalysisDiagnosis of malignant pleural mesotheliomaDeclined surgical resectionEpithelioid histological typeChemotherapy-treated patientsNonsurgically treated patientsStage I diseaseMalignant pleural mesotheliomaMultivariate logistic regression modelPropensity-matched cohortPropensity score matchingI diseaseSurvival benefitHistological typeSurgery 2Prolonged survivalCancer DatabaseDefinitive radiation as a nonsurgical option after chemoimmunotherapy for stage III lung cancer.
Caturegli G, Canavan M, Ayoade O, Woodard G, Boffa D, Resio B. Definitive radiation as a nonsurgical option after chemoimmunotherapy for stage III lung cancer. Journal Of Clinical Oncology 2025, 43: 8072-8072. DOI: 10.1200/jco.2025.43.16_suppl.8072.Peer-Reviewed Original ResearchStage III non-small cell lung cancerIII non-small cell lung cancerNon-small cell lung cancerThree-year overall survivalNonsurgical optionsDefinitive radiationLocal therapyOverall survivalClinical stage III non-small cell lung cancerLung cancerClinical stage III patientsStage III NSCLC patientsStage III lung cancerSquamous cell carcinoma patientsStage III lung adenocarcinomaIII NSCLC patientsInitiation of radiationNon-operative formsCharlson-Deyo scoreIII lung cancerNational Cancer DatabaseStage III patientsTreated with radiationCell carcinoma patientsKaplan-Meier methodSurvival of patients diagnosed with stage IV cancer in 2020 based on COVID-19 status.
Ayoade O, Canavan M, Caturegli G, Zolfaghari E, Resio B, Woodard G, Boffa D. Survival of patients diagnosed with stage IV cancer in 2020 based on COVID-19 status. Journal Of Clinical Oncology 2025, 43 DOI: 10.1200/jco.2025.43.16_suppl.e24041.Peer-Reviewed Original ResearchCancer patient survivalPatient survivalTumor behaviorCOVID-19 infectionCancer typesCharlson-Deyo scoreNational Cancer DatabaseSurvival of patientsKaplan Meier analysisCox proportional hazards modelsStage IV cancerAssociated with lower mortality riskProportional hazards modelCOVID-positive patientsMeier analysisCancer DatabaseLower mortality riskPositive patientsTreatment modalitiesDeyo scoreIV cancerImmune modulationImmunological consequencesCancer patientsYear mortalitySmoking Status of the US Cancer Population and a New Perspective From the National Cancer Database
Caturegli G, Zhu X, Palis B, Mullett T, Resio B, Boffa D. Smoking Status of the US Cancer Population and a New Perspective From the National Cancer Database. JAMA Oncology 2025, 11: 564-566. PMID: 40146125, PMCID: PMC11950973, DOI: 10.1001/jamaoncol.2025.0247.Peer-Reviewed Original Research
2024
Commission on Cancer Standards for Lymph Node Sampling and Oncologic Outcomes After Lung Resection
Resio B, Tan K, Skovgard M, Dycoco J, Adusumilli P, Bains M, Bott M, Downey R, Gray K, Huang J, Molena D, Park B, Rusch V, Sihag S, Rocco G, Jones D, Isbell J. Commission on Cancer Standards for Lymph Node Sampling and Oncologic Outcomes After Lung Resection. The Annals Of Thoracic Surgery 2024, 119: 308-315. PMID: 39299477, PMCID: PMC12453556, DOI: 10.1016/j.athoracsur.2024.09.009.Peer-Reviewed Original ResearchConceptsClinical stage IClinical stage III patientsStage III patientsStage IIII patientsLung resectionHilar lymph node stationsRate of nodal upstagingSystemic therapy administrationProspective institutional databaseLung cancer resectionLymph node stationsIn-Hospital ComplicationsLymph node samplingLung cancer patientsDistant recurrenceNodal upstagingOncological outcomesPulmonary resectionOverall survivalCancer resectionDecrease recurrenceClinical stageII patientsImproved survival
2022
Impact of bowel preparation on elective colectomies for diverticulitis: analysis of the NSQIP database
Zhuo H, Liu Z, Resio B, Liu J, Wang X, Pei K, Zhang Y. Impact of bowel preparation on elective colectomies for diverticulitis: analysis of the NSQIP database. BMC Gastroenterology 2022, 22: 415. PMID: 36096764, PMCID: PMC9469520, DOI: 10.1186/s12876-022-02491-8.Peer-Reviewed Original ResearchConceptsAntibiotic bowel preparationMechanical bowel preparationSurgical site infectionAnastomotic leakageBowel preparationElective colectomyRisk of SSIMultivariate logistic regression modelElective colorectal surgeryLogistic regression modelsBackgroundRecent dataPostoperative complicationsColorectal surgeryDiverticulitis patientsSite infectionStudy designWePotential confoundersLaparoscopic surgeryImproved outcomesAmerican CollegeLower riskColectomyPatientsSurgery proceduresFurther stratification
2020
Surgically Managed Signet Ring Cell Esophageal Carcinomas in the National Cancer Database
Sathe TS, Resio BJ, Hoag JR, Monsalve AF, Pathak R, Blasberg JD, Mase V, Dhanasopon A, Boffa DJ. Surgically Managed Signet Ring Cell Esophageal Carcinomas in the National Cancer Database. The Annals Of Thoracic Surgery 2020, 109: 1656-1662. PMID: 32109449, DOI: 10.1016/j.athoracsur.2020.01.021.Peer-Reviewed Original ResearchConceptsSignet ring cell adenocarcinomaNational Cancer DatabaseSRC tumorsACA patientsCancer DatabaseProportional hazards regression modelsCommon histologic variantRole of esophagectomyClinical stage IRole of surgeryHazards regression modelsHigh-grade tumorsSRC histologySRC patientsAdult patientsComplete resectionWorse prognosisCell adenocarcinomaEsophageal cancerEsophageal carcinomaHistologic variantsSuperior survivalEsophageal adenocarcinomaTreatment characteristicsClinical recommendationsCharacterization of High Mortality Probability Operations at National Surgical Quality Improvement Program Hospitals
Resio BJ, Chiu AS, Zhang Y, Pei KY. Characterization of High Mortality Probability Operations at National Surgical Quality Improvement Program Hospitals. JAMA Surgery 2020, 155: 85-88. PMID: 31664436, PMCID: PMC6822090, DOI: 10.1001/jamasurg.2019.3750.Peer-Reviewed Original ResearchMeSH KeywordsAge FactorsAgedAged, 80 and overClostridium InfectionsCohort StudiesColitisDatabases, FactualFemaleHospitalsHumansIntestinal PerforationMaleMesenteric IschemiaMiddle AgedNeoplasmsPersons with DisabilitiesQuality Assurance, Health CareQuality ImprovementRespiration, ArtificialRisk AssessmentSepsisShock, SepticSurgical Procedures, OperativeUnited States
Clinical Care
Overview
Benjamin Resio, MD, is a thoracic surgeon who treats the entire spectrum of thoracic surgical diseases. He has a special interest in thoracic surgical oncology, multidisciplinary care for lung and esophageal cancer, and minimally invasive and robotic surgery. Dr. Resio cares for patients as part of the Center for Thoracic Cancers at Smilow Cancer Hospital.
Also an assistant professor of surgery at Yale School of Medicine, Dr. Resio received his medical degree with honors from Dartmouth Medical School, where he was elected to the Alpha Omega Alpha honor society. He completed his residency at Yale School of Medicine, followed by a fellowship in cardiothoracic surgery at Memorial Sloan Kettering Cancer Center.
Clinical Specialties
Thoracic Surgery
Yale Medicine News
Get In Touch
Contacts
Appointment Number